参考文献/References:
[1] Chen JB, Lei D, He M, et al. Clinical features and disease progression in moyamoya disease patients with Graves' disease[J].J Neurosurg,2015,123(4):848-855. DOI: 10.3171/2014.10.JNS141140.
[2] Li D, Yang W, Xian P,et al. Coexistence of moyamoya and Graves' diseases: the clinical characteristics and treatment effects of 21 Chinese patients[J].Clin Neurol Neurosurg, 2013,115(9):1647-1652. DOI: 10.1016/j.clineuro.2013.02.018.
[3] Hsu SW, Chaloupka JC, Fattal D. Rapidly progressive fatal bihemispheric infarction secondary to Moyamoya syndrome in association with Graves' thyrotoxicosis[J].AJNR Am J Neuroradiol,2006,27(3):643-647.
[4] Suzuki S, Mitsuyama T, Horiba A,et al. Moyamoya disease complicated by Graves' disease and type 2 diabetes mellitus: report of two cases[J].Clin Neurol Neurosurg, 2011,113(4):325-329. DOI: 10.1016/j.clineuro.2010.11.022.
[5] Lee R, Sung K, Park YM,et al. A case of Moyamoya disease in a girl with thyrotoxicosis[J].Yonsei Med J, 2009,50(4):594-598. DOI: 10.3349/ymj.2009.50.4.594.
[6] Kim JY, Kim BS, Kang JH. Dilated cardiomyopathy in thyrotoxicosis and Moyamoya disease[J].Int J Cardiol,2001,80(1):101-103.
[7] Ni J, Zhou LX, Wei YP,et al. Moyamoya syndrome associated with Graves' disease: a case series study[J].Ann Transl Med,2014,2(8):77.DOI: 10.3978/j.issn.2305-5839.2014.08.03.
[8] Tokimura H, Tajitsu K, Takashima H,et al. Familial moyamoya disease associated with Graves' disease in a mother and daughter. Two case reports[J].Neurol Med Chir(Tokyo), 2010,50(8):668-674.
[9] Tanaka M, Sakaguchi M, Yagita Y,et al. Thyroid antibodies are associated with stenotic lesions in the terminal portion of the internal carotid artery[J].Eur J Neurol, 2014,21(6):867-873.DOI: 10.1111/ene.12397.
[10] Jehangir W, Singh Z, Bhatt H, et al. A new early finding of moyamoya-like phenomena[J].J Clin Med Res, 2015,7(8):643-645. DOI: 10.14740/jocmr2193w.
[11] Inaba M, Henmi Y, Kumeda Y,et al. Increased stiffness in common carotid artery in hyperthyroid Graves' disease patients[J].Biomed Pharmacother, 2002,56(5):241-246.
[12] Colleran KM, Ratliff DM, Burge MR. Potential association of thyrotoxicosis with vitamin B and folate deficiencies, resulting in risk for hyperhomocysteinemia and subsequent thromboembolic events[J].Endocr Pract, 2003,9(4):290-295.